Pricing Log in Create free account

Vyome Holdings, Inc. (HIND) vs Pasithea Therapeutics Corp. (KTTA)

Vyome Holdings, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Vyome Holdings, Inc. and Pasithea Therapeutics Corp. are of similar size ($13.7M and $13.4M). Pasithea Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −8,711.7%) and the lower return on invested capital (−367.5% vs 0.00%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 9 and Vyome Holdings, Inc. on 6.

Valuation

Metric HIND KTTA Biotechnology median
P/E 0.00 n/m 8.50
P/S 101.12 27.71 9.71
P/B 1.80 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.39 0.64
EV/Sales 138.64 (66.34) 9.21
Earnings yield 81,732.03% (376.19%) (33.15%)
Free cash flow yield (42.50%) (130.85%) (25.50%)

Profitability

Metric HIND KTTA Biotechnology median
Gross margin 52.77% 0.00% 65.16%
Operating margin (9,184.82%) 0.00% 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (65.49%) (56.36%)
Return on assets (124.23%) (61.97%) (48.04%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric HIND KTTA Biotechnology median
Revenue growth (TTM) 103.81% — 6.02%
EPS growth (last fiscal year) 99.92% 77.07% 30.26%
Revenue growth, 5-year CAGR (50.98%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 26.25 4.72
Net debt to EBITDA 0.48 2.74 0.96

Dividend

Metric HIND KTTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HIND KTTA Biotechnology median
Market cap 13.41m 13.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack